L04AB04 |
BioTech |
Adalimumab - 40mg/0.4ml |
9597 |
135418/1 |
HUMIRA |
40mg/0.4ml |
2 x 0.4ml |
Injectable solution |
SC |
Interpharma S.A.L. |
Vetter Pharma- Fertigung GmbH & Co KG |
Germany |
33,860,031 L.L |
10.71 |
E1 |
Abbvie Deutschland GmbH & Co KG |
Germany |
03/04/20 |
|
L04AB04 |
BioTech |
Adalimumab - 40mg/0.8ml |
10085 |
125519/1 |
CINNORA |
40mg/0.8ml |
2 |
Injectable solution |
SC |
Lebiran SARL |
Cinnagen Co |
Iran |
14,817,734 L.L |
19.35 |
D |
Cinnagen Co |
Iran |
03/04/20 |
|
L04AB04 |
BioTech |
Adalimumab - 40mg |
11325 |
147822/1 |
ABRILADA |
40mg |
2 |
Injectable solution |
SC |
Food & Drug Corporation FDC |
Catalent Indiana, LLC |
USA |
40,259,574 L.L |
10.71 |
E1 |
Pfizer Europe MA EEIG |
Belgium |
03/04/20 |
|
L04AB04 |
BioTech |
Adalimumab - 40mg |
11326 |
147922/1 |
ABRILADA |
40mg |
2 |
Injectable solution |
SC |
Food & Drug Corporation FDC |
Catalent Indiana, LLC |
USA |
40,259,574 L.L |
10.71 |
E1 |
Pfizer Europe MA EEIG |
Belgium |
03/04/20 |
|
L04AB04 |
BioTech |
Adalimumab - 40mg |
11585 |
106523/1 |
ADALIREL |
40mg |
1x0.8ml |
Injectable solution |
SC |
Levant Pulse SARL |
Reliance Life Sciences pvt Ltd |
India |
15,102,158 L.L |
19.35 |
D |
Reliance Life Sciences pvt Ltd |
India |
03/04/20 |
|
L04AB04 |
BioTech |
Adalimumab - 40mg |
9748 |
41219/1 |
HYRIMOZ |
40mg |
2 |
Injectable solution |
SC |
Khalil Fattal & Fils S.A.L. |
Sandoz GmbH, (Schaftenau) |
Austria |
26,053,947 L.L |
10.71 |
E1 |
Sandoz GmbH, Kundl |
Austria |
03/04/20 |
|
L04AB04 |
BioTech |
Adalimumab - 40mg/0.4ml |
9597/388 |
135418/1 |
HUMIRA |
40mg/0.4ml |
2 x 0.4ml |
Injectable solution |
SC |
Interpharma S.A.L. |
Vetter Pharma- Fertigung GmbH & Co KG |
Germany |
L.L |
10.71 |
E1 |
Abbvie Deutschland GmbH & Co KG |
Germany |
05/02/20 |
|